Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Blood Loss in PAS Cesarean Hysterectomy
NCT06493968Recruiting
- Sponsor
- Cairo University
- Start
- Jul 2024
- Primary completion
- Dec 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised trial in Placenta accreta spectrum (PAS) comparing Oxytocin Group with Placebo Group (2 arms). Primary endpoint: Intraoperative blood loss. Started Jul 2024; status: recruiting.
02
Drugs
oxytocin
03
Conditions
Placenta accreta spectrum (PAS)
Beyond the preview
Go deeper on NCT06493968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06493968.